Biohaven Pharma (BHVN) Misses Q2 EPS by 172c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| (NYSE: BHVN) | Delayed: 15.77 +0.35 (2.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.42 | 52 Week High | $ | |||
| Open | $15.98 | 52 Week Low | $ | |||
| Day High | $16.11 | P/E | N/A | |||
| Day Low | $15.52 | EPS | $ | |||
| Volume | 213,448 | |||||
